$69.99 0.00 (0%)
11/24/2008 4:00 PM

ImClone Systems, Inc. (IMCL.DL)

CAPS Rating: No stars

A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.

Current Price $69.99 Mkt Cap $6.22B
Open $0.00 P/E Ratio 105.98
Prev. Close $69.99 Div. (Yield) N/A (N/A)
Daily Range $69.98 - $70.01 Volume 0
52-Wk Range $36.87 - $70.01 Avg. Daily Vol. 0

Related News and Articles

Caps

This ticker is not currently Ratable.

Add Stock to Watchlist

All Members

0 Outperform
0 Underperform
 

All-Star Members

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top IMCL.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

NetscribeBiotech (34.27)
Submitted March 12, 2007

ImClone Systems Incorporated (ImClone) is a biopharmaceutical company that is focused on development of oncology therapeutics. With various drugs in the pipeline, addressing the medical needs of patients affected with cancer, the company’s only… More

1 Comment | Reply | Report this Post

TMFPeterJ (< 20)
Submitted August 28, 2006

You hate to vote against stock in a company doing something as vital as cancer research. But IMCL's track record suggests its research could produce better results in the hands of a more well-run biotech.

2 Comments | Reply | Report this Post
IMCL.DL VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about IMCL.DL.

No one has written a Pitch for IMCL.DL stock yet. Tell us why you think IMCL.DL will outperform or underperform the S&P 500.

Leaderboard

Find the members with the highest scoring picks in IMCL.DL.

No players have picked IMCL.DL yet. Tell us why you think IMCL.DL will outperform or underperform the S&P 500.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackRichAster 91.02 6/17/2008 Outperform 1Y $38.57 +81.46% -37.90% +119.36 11/25/2008 @ $69.99 1 Comment
TrackLeerinkSwan 83.04 5/30/2008 Outperform NS $43.08 +62.47% -38.70% +101.17 11/25/2008 @ $69.99
TrackEveillard 88.00 3/31/2008 Outperform NS $42.42 +64.99% -34.87% +99.87 11/25/2008 @ $69.99 1 Comment
TrackCitigroup < 20 3/19/2008 Outperform NS $44.81 +42.16% -6.02% +48.17 8/1/2008 @ $63.70
TrackCowenandCo 69.87 2/22/2008 Outperform NS $40.90 +71.12% -37.00% +108.13 11/25/2008 @ $69.99
TrackSoros 24.12 9/30/2007 Outperform NS $41.34 +69.30% -44.27% +113.58 11/25/2008 @ $69.99 1 Comment
TrackBearStearns 81.70 9/11/2007 Outperform NS $45.89 +52.52% -41.92% +94.43 11/25/2008 @ $69.99
TrackPiperJaff 78.45 9/5/2007 Outperform NS $34.76 +101.35% -42.62% +143.98 11/25/2008 @ $69.99
TrackStanfordRes 78.48 8/1/2007 Outperform NS $32.66 +113.90% -44.42% +158.32 11/20/2008 @ $69.86
TrackRodmanRen < 20 4/4/2007 Outperform NS $42.12 +66.17% -39.06% +105.23 11/25/2008 @ $69.99
TrackJanney 63.32 3/23/2007 Outperform NS $37.80 +85.16% -40.77% +125.93 11/25/2008 @ $69.99
TrackHSBC 90.54 3/23/2007 Outperform NS $38.91 +79.88% -40.65% +120.53 11/25/2008 @ $69.99
TrackFBRCapitalM 73.72 3/22/2007 Outperform NS $33.30 +25.17% +3.19% +21.98 9/14/2007 @ $41.68
TrackJimCramer 36.31 11/6/2006 Underperform 3W $31.17 +124.54% -38.75% -163.29 11/25/2008 @ $69.99
TrackFBRCapitalM 73.72 9/28/2006 Underperform NS $27.79 -0.58% +6.38% +6.95 1/29/2007 @ $27.63

Featured Broker Partners